SCHEMBL21245479

SCHEMBL21245479

CC(CCC(CN)C(=O)O)COCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SLC1A1 P43005 1/20 0.55
▸ FOLH1 Q04609 2/20 0.43
▸ SLC15A1 P46059 1/20 0.42
▸ MME P08473 1/20 0.41
▸ CA1 P00915 3/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ TACR1 P25103 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PPARA Q07869 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ MMP9 P14780 1/20 0.39
▸ MMP14 P50281 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27523288 0.84 SLC1A1 (0.50) SLC1A1FOLH1MMECA1CA2
SCHEMBL4985838 0.81 CYP1A2 (0.55) SLC1A1FOLH1CYP1A2
SCHEMBL4989295 0.80 GRIK1 (0.47) KMT2ACYP1A2
SCHEMBL28225061 0.79 TACR1 (0.49) SLC1A1CA1CA2CA7CA9
SCHEMBL26330565 0.78 TSHR (0.52) SLC1A1CA1CA2CA7CA9
SCHEMBL5941636 0.78 SLC1A1 (0.61) SLC1A1FOLH1CA1CA2CA7
SCHEMBL5870182 0.78 FOLH1 (0.58) SLC1A1FOLH1CA1CA2CA7
SCHEMBL5941631 0.78 SLC1A1 (0.61) SLC1A1FOLH1CA1CA2CA7
SCHEMBL11073343 0.78 SLC1A1 (0.55) SLC1A1FOLH1KMT2A
SCHEMBL10812169 0.78 SLC1A1 (0.55) SLC1A1FOLH1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250127733-A1 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT ALDEYRA THERAPEUTICS, INC. 2025-04-24 — — US disclosed
US-11701331-B2 Toxic aldehyde related diseases and treatment ALDEYRA THERAPEUTICS, INC. (US) 2023-07-18 — — US disclosed
US-20210275469-A1 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT ALDEYRA THERAPEUTICS, INC. 2021-09-09 — — US disclosed
US-11007157-B2 Toxic aldehyde related diseases and treatment ALDEYRA THERAPEUTICS, INC. (US) 2021-05-18 — — US disclosed
US-10588874-B2 Toxic aldehyde related diseases and treatment ALDEYRA THERAPEUTICS, INC. (US) 2020-03-17 — — US disclosed
US-20190247334-A1 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT ALDEXA THERAPEUTICS, INC. 2019-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275469-A1 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT ALDH1A2, ALDH2, ALDH1A1 SLC1A1 240/4885FOLH1 1388/4885SLC15A1 1460/4885
US-20190247334-A1 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT ALDH1A2, ALDH2, ALDH1A1 SLC1A1 240/4885FOLH1 1388/4885SLC15A1 1460/4885
US-11007157-B2 Toxic aldehyde related diseases and treatment ALDH1A2, ALDH2, ALDH1A1 SLC1A1 240/4885FOLH1 1388/4885SLC15A1 1460/4885
US-10588874-B2 Toxic aldehyde related diseases and treatment ALDH1A2, ALDH2, ALDH1A1 SLC1A1 240/4885FOLH1 1388/4885SLC15A1 1460/4885
US-20250127733-A1 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT ALDH1A2, ALDH2, ALDH1A1 SLC1A1 240/4885FOLH1 1388/4885SLC15A1 1460/4885
US-11701331-B2 Toxic aldehyde related diseases and treatment ALDH1A2, ALDH2, ALDH1A1 SLC1A1 240/4885FOLH1 1388/4885SLC15A1 1460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback